查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654686

全球乳房 X 光攝影機市場 - 2025 至 2033 年

Global Mammography Machine Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 168 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球乳房 X 光攝影機市場規模達到 26 億美元，預計到 2033 年將達到 41 億美元，2025-2033 年預測期內的複合年成長率為 5.1%。

乳房 X 光檢查機是一種專門的醫學影像設備，透過捕捉乳房組織的詳細 X 光影像（稱為乳房 X 光檢查）來早期發現和診斷乳癌。乳房 X 光攝影機的主要目的是檢測腫塊、腫瘤、鈣化等異常情況，或其他可能表明乳癌或其他疾病的跡象，通常是在任何症狀出現之前。

對無症狀女性進行篩檢性乳房 X 光攝影，以發現乳癌的早期跡象；當出現腫塊、疼痛或先前篩檢發現的異常等跡像或症狀時，進行診斷性乳房 X 光攝影；追蹤性乳房 X 光攝影用於監測先前發現的病症或手術或放射治療等治療後的情況。

由於多種因素，包括乳癌病例的增加、技術進步和政府健康計劃，對乳房 X 光攝影機的需求一直在增加。在乳癌篩檢、診斷和追蹤中乳房X光檢查機的日益普及也是推動市場需求的重要因素。例如，2024 年 6 月，FUJIFIM India Healthcare 與 NM Medical Mumbai 合作，推出了首個富士膠片技能實驗室，為放射科醫生和放射技師提供 FFDM（全視野數位乳房 X 光攝影）技術的高級培訓。

市場動態：

促進因素與約束因素

乳癌發生率上升

乳癌發生率的上升極大地推動了乳房X光檢查機市場的成長，預計在預測期內仍將推動市場的發展。根據世界衛生組織 (WHO) 的數據，2022 年，有 230 萬名女性被診斷出罹患乳癌。乳癌影響青春期後各年齡層的女性，但其發生率在後期有所上升。此外，根據乳癌組織的數據，到 2024 年，美國約有 310,720 名女性被診斷出患有侵襲性乳癌，其中 16% 是年齡在 50 歲以下的女性。發病率的不斷成長使得需要早期篩檢以進行診斷和治療的患者數量不斷增加。

乳癌的早期診斷可大幅提高治療效果和存活率。乳房 X 光攝影是乳癌篩檢的黃金標準，尤其是對於 40 歲以上的女性。乳癌的風險隨著年齡的成長而增加。根據美國癌症協會統計，約80%的乳癌病例發生在50歲以上的女性身上。

乳癌宣傳月和粉紅絲帶運動等計劃大大提高了公眾對早期乳癌發現重要性的認知。這導致乳房X光照射機器的需求不斷增加，特別是在印度、中國和巴西等新興市場，由於生活方式的改變和人口老化，這些地區的乳癌發病率正在上升。

乳房X光檢查機價格昂貴

乳房X光檢查機的高成本是乳房X光檢查機市場成長的重大障礙，尤其是在資源匱乏的地區和發展中國家。乳房X光檢查機的成本可能有所不同，但入門級機器的平均價格範圍為 55,000 美元至 75,000 美元。現代數位乳房X光攝影和3D乳房X光攝影（斷層合成）系統的成本可能相當高。數位乳房 X 光攝影機的價格從每台 15 萬美元到 30 萬美元不等，具體取決於其功能（例如 AI 整合和高級成像功能）。

乳房X光檢查機的高昂維護費用增加了總體經濟負擔。這些機器需要定期校準、簽訂服務合約和軟體更新，這可能會導致額外的費用。膠片（用於較舊的模擬系統）或一次性成像組件等消耗品以及維護備件都會增加持續成本。需要訓練有素的專業人員來操作和維護這些系統也增加了營運成本。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 依產品類型分類
  • 技術片段
  • 按維度截取片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 乳癌發生率上升
    • 限制
      • 乳房X光檢查機價格昂貴
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • 新興創業公司和關鍵創新者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：乳房 X 光攝影機市場（依產品類型）

  • 數位乳房攝影機
  • 模擬乳房X光攝影機

第 6 章：乳房 X 光攝影機市場（按技術分類）

  • 螢幕膠卷乳房X光檢查
  • 全視野數位化乳房攝影

第 7 章：乳房 X 光攝影機市場（依尺寸）

  • 2D
  • 3D

第 8 章：乳房 X 光攝影機市場（按應用）

  • 乳房X光檢查
  • 診斷性乳房X光檢查
  • 追蹤乳房 X 光攝影

第 9 章：乳房 X 光攝影機市場（按最終用戶分類）

  • 醫院
  • 診斷中心
  • 專科診所
  • 其他

第 10 章：乳房 X 光攝影機市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 12 章：公司簡介

  • GE HealthCare
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
    • SWOT 分析
  • Siemens Healthineers AG
  • Hologic, Inc.
  • FUJIFILM Holdings Corporation
  • PLANMED OY
  • Koninklijke Philips NV
  • Metaltronica SpA
  • Konica Minolta Healthcare Americas, Inc.
  • Carestream Health
  • CANON MEDICAL SYSTEMS ARGENTINA SA

第 13 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 14 章：附錄

簡介目錄
Product Code: MI9131

The global mammography machine market reached US$ 2.6 billion in 2024 and is expected to reach US$ 4.1 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2025-2033.

A mammography machine is a specialized medical imaging device used for early detection and diagnosis of breast cancer by capturing detailed X-ray images (called mammograms) of the breast tissue. The primary purpose of the mammography machine is to detect abnormalities such as lumps, tumors, calcifications, or other signs that could indicate breast cancer or other medical conditions, often before any symptoms are noticeable.

Screening mammography is performed on asymptomatic women to detect early signs of breast cancer, diagnostic mammography is performed when there are signs or symptoms such as lumps, pain, or abnormal findings from a previous screening, follow-up mammography is used to monitor previously identified conditions or after treatments like surgery or radiation.

The demand for mammography machines has been increasing due to several factors, including the rise in breast cancer cases, advancements in technology and government health initiatives. The rising adoption of mammography machines for breast cancer screening, diagnosis and follow-ups is also a significant factor driving the market demand. For instance, in June 2024, FUJIFIM India Healthcare in collaboration with NM Medical Mumbai, launched its first Fujifilm Skill Lab for providing advanced training in FFDM (full-field digital mammography) technologies for radiologists and radiographers.

Market Dynamics: Drivers & Restraints

Rising prevalence of breast cancer

The rising prevalence of breast cancer is significantly driving the growth of the mammography machine market and is expected to drive the market over the forecast period. According to the World Health Organization (WHO), in 2022, 2.3 million women were diagnosed with breast cancer. Breast cancer affects women of all ages after puberty, although the incidence rises later in life. Additionally, according to the Breast Cancer Organization, in 2024, approximately 310,720 women diagnosed with invasive breast cancer, 16% of which will be in women younger than 50 years of age in the United States. This growing incidence creates a larger pool of patients who require early screening for diagnosis and treatment.

Early diagnosis of breast cancer greatly improves treatment outcomes and survival rates. Mammography is the gold standard for breast cancer screening, especially for women over the age of 40. This increasing focus on early detection drives greater adoption of mammography machines. The risk of breast cancer increases with age. According to the American Cancer Society, about 80% of breast cancer cases are diagnosed in women over the age of 50. As the global population ages, particularly in countries with longer life expectancies, the demand for mammography machines for regular screenings continues to grow.

Initiatives like Breast Cancer Awareness Month and the Pink Ribbon Campaign have significantly increased public awareness of the importance of early breast cancer detection. This has contributed to rising demand for mammography machines, particularly in emerging markets such as India, China, and Brazil, where breast cancer rates are rising due to lifestyle changes and aging populations.

High cost of mammography machines

The high cost of mammography machines is a significant barrier to the growth of the mammography machine market, especially in low-resource settings and developing countries. The cost of a mammography machine can vary however the average price range for an entry-level machine is $55,000 to $75,000. The cost of modern digital mammography and 3D mammography (Tomosynthesis) systems can be quite high. A digital mammography machine can range from USD 150,000 to USD 300,000 per unit, depending on the features (e.g., AI integration and advanced imaging capabilities).

The high maintenance costs of mammography machines add to the total financial burden. These machines require regular calibration, service contracts and software updates, which can lead to additional expenses. Consumables such as film (for older analog systems) or disposable imaging components and spare parts for maintenance contribute to ongoing costs. The need for trained professionals to operate and maintain these systems also increases operational costs.

Segment Analysis

The global mammography machine market is segmented based on product type, technology, dimension, application, end-user and region.

Product Type:

The digital mammography machine segment is expected to dominate the mammography machine market share

Digital mammography machines provide faster breast screening which further helps to promote early diagnosis of breast cancer. The ability to instantly view and store images digitally speeds up the process, improving workflow efficiency and reducing wait times for patients. With digital systems, images are available within minutes, which allows for quick diagnosis and reduced patient anxiety. Digital mammography reduces the need for physical films and manual development processes, making it more cost-effective in the long term.

For instance, in June 2024, Healthway Medical Network (HMN) launched a new digital mammography machine at its multi-specialty center. This new device offers high-resolution imaging for breast cancer screening, enabling the center's doctors to identify potential abnormalities with better accuracy. Moreover, its adoption is aligned with HMN's initiative of offering comprehensive screenings to promote early diagnosis among patients.

Digital mammography provides better image clarity and higher diagnostic accuracy compared to traditional film-based mammography, particularly for women with dense breast tissue. The ability to digitally manipulate images (contrast, zoom, etc.) also aids in detecting early-stage cancers that might be missed in film mammography.

Geographical Analysis

North America is expected to hold a significant position in the mammography machine market share

Breast cancer is the most common cancer among women in North America especially in the United States and Canada, with a significantly higher incidence compared to many other regions. For instance, according to the American Cancer Society, breast cancer is the second most frequent cancer in women in the United States, and it is the top cause of cancer mortality among Hispanic women. In 2024, 310,720 women were diagnosed with invasive breast cancer, with a projected 42,250 deaths. This high prevalence drives the demand for breast cancer screening and diagnostic tools like mammography machines.

Additionally, according to the Canadian Cancer Society, in 2022, an estimated 28,600 Canadian women were diagnosed with breast cancer. With increasing breast cancer cases, awareness about breast cancer and its early detection is also rising, there is a strong demand for mammography screenings in North America, particularly for women aged 40 and above. Mammography remains the gold standard for early breast cancer detection in the region.

North America has been a leader in the adoption of advanced mammography technologies, such as digital mammography and 3D mammography (tomosynthesis). The adoption of Full-Field Digital Mammography (FFDM) and 3D systems has been particularly strong, thanks to their higher diagnostic accuracy and better detection rates compared to traditional film-based systems.

For instance, in January 2025, GRACE Breast Imaging & Medical Spa of Iowa recently became the first healthcare facility in the United States to install the new Mammomat B.brilliant. The Mammomat B.brilliant is Siemens Healthineers' first completely redesigned mammography machine in over a decade. It includes new 3D image acquisition and reconstruction technology, as well as features for full-field digital mammography or two-dimensional breast imaging, breast biopsy, and titanium contrast-enhanced mammography.

Asia-Pacific is growing at the fastest pace in the mammography machine market

Awareness campaigns focused on early detection and screening are significantly raising the demand for mammography machines in the region. As breast cancer awareness rises, more women are seeking regular screening, driving the need for modern mammography equipment. In countries like India and China, breast cancer awareness is gradually increasing due to efforts by non-profit organizations, media, and healthcare professionals. These campaigns are encouraging women to get screened regularly, which directly drives demand for mammography machines.

For instance, Breast Cancer Awareness Month, commemorated every October, has a unique importance worldwide, but notably in India. In a nation where breast cancer is growing more common, this awareness month acts as an important effort to educate, empower, and motivate action. This has led to greater utilization of mammography services in metropolitan and rural regions.

Competitive Landscape

The major global players in the mammography machine market include GE HealthCare, Siemens Healthineers AG, Hologic, Inc., FUJIFILM Holdings Corporation, PLANMED OY, Koninklijke Philips N.V., Metaltronica S.p.A., Konica Minolta Healthcare Americas, Inc., Carestream Health, CANON MEDICAL SYSTEMS ARGENTINA S.A. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global mammography machine market report delivers a detailed analysis with 78 key tables, more than 70 visually impactful figures, and 168 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Dimension
  • 2.6. Snippet by Application
  • 2.7. Snippet by End-User
  • 2.8. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Breast Cancer
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Mammography Machines
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Mammography Machine Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Digital Mammography Machine*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Analog Mammography Machine

6. Mammography Machine Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Screen-Film Mammography*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Full Field Digital Mammography

7. Mammography Machine Market, By Dimension

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 7.1.2. Market Attractiveness Index, By Dimension
  • 7.2. 2D*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. 3D

8. Mammography Machine Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Screening Mammography*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Diagnostic Mammography
  • 8.4. Follow-up Mammography

9. Mammography Machine Market, By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. Mammography Machine Market, By Regional Market Analysis and Growth Opportunities

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.8.1. U.S.
      • 10.2.8.2. Canada
      • 10.2.8.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.8.1. Germany
      • 10.3.8.2. U.K.
      • 10.3.8.3. France
      • 10.3.8.4. Spain
      • 10.3.8.5. Italy
      • 10.3.8.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.8.1. Brazil
      • 10.4.8.2. Argentina
      • 10.4.8.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. South Korea
      • 10.5.8.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Dimension
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape and Market Positioning

  • 11.1. Competitive Overview and Key Market Players
  • 11.2. Market Share Analysis and Positioning Matrix
  • 11.3. Strategic Partnerships, Mergers & Acquisitions
  • 11.4. Key Developments in Product Portfolios and Innovations
  • 11.5. Company Benchmarking

12. Company Profiles

  • 12.1. GE HealthCare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Siemens Healthineers AG
  • 12.3. Hologic, Inc.
  • 12.4. FUJIFILM Holdings Corporation
  • 12.5. PLANMED OY
  • 12.6. Koninklijke Philips N.V.
  • 12.7. Metaltronica S.p.A.
  • 12.8. Konica Minolta Healthcare Americas, Inc.
  • 12.9. Carestream Health
  • 12.10. CANON MEDICAL SYSTEMS ARGENTINA S.A.

LIST NOT EXHAUSTIVE

13. Assumption and Research Methodology

  • 13.1. Data Collection Methods
  • 13.2. Data Triangulation
  • 13.3. Forecasting Techniques
  • 13.4. Data Verification and Validation

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us